Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for ...
Bright Side on MSN
Bio-computing breakthrough: A new era of human cell technology
A groundbreaking advancement in technology has emerged: scientists have developed a bio-computer using human cells. This ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
The era of "biomanufacturing," in which microbes, not petroleum, produce chemical products, is one step closer. A KAIST research team has analyzed the key challenges limiting the commercialization of ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced an alliance with bit.bio to create a comprehensive map of ...
The Chosun Ilbo on MSN
US bio investment curbs open door for South Korean firms
The strategic competition between the U.S. and China is expanding beyond semiconductors and AI (artificial intelligence) into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results